Blog

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Blog

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

Photo from faculty.mdanderson.org

Jun 26, 2023, 18:40

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

In a post by Jared K. Burks on Linkedin, it says, “This is a double celebration as not only did I get to contribute to this wonderful article, but the first author, Russell Pourebrahim was just promoted to Assistant Professor. Congrats Rasoul on both the article and the promotion, very happy for you.
Mesenchymal stromal cells (MSCs) are a key component of the bone marrow (BM) niche, providing essential support required for the maintenance of hematopoietic stem cells. To advance our understanding of physiological functions of p53 and Mdm2 in BM-MSCs, we developed traceable conditional mouse models targeting Mdm2 and/or Trp53 in vivo. Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML and expand our understanding of the mechanism of hematopoietic toxicity of MDM2is.”

For Article : Click here

Source:

bone marrow cancer cancer care hematopoietic Jared K. Burks Mesenchymal stromal cells Oncology Research Russell Pourebrahim

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Insight

Dec 22, 2024, 00:21

Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed

Blog

Dec 21, 2024, 22:40

50 Years of History, a Future to Write Together - AIEOP

Science

Dec 21, 2024, 22:37

Breaking Down the Impact of Ionizing Radiation on Cancer

Blog

Dec 21, 2024, 22:35

Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress

Blog

Dec 21, 2024, 22:33

ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms

Blog

Dec 21, 2024, 22:28

Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer

Blog

Dec 21, 2024, 22:26

Anas Younes: Transforming outcomes for people living with Blood Cancer

Blog

Dec 21, 2024, 19:42

Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials

Blog

Dec 21, 2024, 19:39

Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers

Blog

Dec 21, 2024, 19:25

Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation

Blog

Dec 21, 2024, 19:21

Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025

Blog

Dec 21, 2024, 19:19

Registration and abstract submission open for the PTCOG63 - SIOP Europe